Silicon Valley | New York

Technologies

Pharmaceuticals

  • Composition/Molecule (API)
  • Formulation
  • Dosage form
  • Method of manufacture
  • Method of treatment
  • Method of use
  • Racemate and enantiomer
  • Impurities and related compounds in the API
  • Intermediates used in making the API
  • Process for making the API/formulation
  • Polymorphic forms and particle size of API
  • Formulations
  • Pharmacokinetics
  • Dissolution profile
  • Dosage form characteristics
  • Combination of two active ingredients


Biologics

  • Radiolabeled antibodies
  • Recombinant cloning vehicles
  • Methods of microbial expression of polypeptides
  • Method for inhibiting cell growth control factors
  • Recombinant erythropoietin
  • Enoxaparin sodium

Biosimilars

  • Composition 
  • Formulation 
  • Protein purification/downstream processing
  • Method of administration
  • Method of treatment
  • Dosage form

Medical Devices

  • Robotic radiosurgery systems
  • Cardiac defibrillators
  • Stents
  • Drug-eluting stents
  • Medical fluid injectors
  • Implantable cardiac devices

Digital Health

Financial Services and SaaS